SEP 16 2026
Telix Pharmaceuticals Limited — Pixclara (TLX101-Px) $TLX
for brain cancer imaging
Accepted APR 10 2026.
for brain cancer imaging
Accepted APR 10 2026.
Glioblastoma is an aggressive brain tumor that grows rapidly and often resists treatment, leading to poor survival rates. Pixclara is a diagnostic imaging agent that binds to specific markers on glioblastoma cells, making them visible under medical scans. This targeting could help doctors more accurately map tumors for surgical removal or radiation planning.